Dexcom (DXCM) EPS (Diluted) Growth (1y) (2014 - 2026)
Powered by 
Analysis
Dexcom (DXCM) EPS (Diluted) Growth (1y) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.51 Bn | 177.91 Bn | 7.27 Bn | -47.60% |
| 2 | Intuitive Surgical | 124.70 Bn | 119.48 Bn | 1.96 Bn | 26.30% |
| 3 | Medtronic | 117.95 Bn | 109.13 Bn | 6.34 Bn | 41.58% |
| 4 | Stryker | 106.08 Bn | 102.61 Bn | 4.50 Bn | 44.49% |
| 5 | Boston Scientific | 66.53 Bn | 65.99 Bn | 3.85 Bn | 15.24% |
| 6 | Edwards Lifesciences | 49.51 Bn | 45.26 Bn | 1.35 Bn | -25.88% |
| 7 | Alcon | 33.90 Bn | 32.44 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.09 Bn | 30.14 Bn | 830.00 Mn | 44.97% |
| 9 | Steris | 21.06 Bn | 20.58 Bn | 684.20 Mn | 13.96% |
| 10 | Zimmer Biomet Holdings | 18.27 Bn | 17.86 Bn | 1.54 Bn | 33.83% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 44.97% |
| Mar 31, 2026 | 95.96% |
| Dec 31, 2025 | 79.33% |
| Sep 30, 2025 | 112.30% |
| Jun 30, 2025 | 27.94% |
| Mar 31, 2025 | -26.38% |
| Dec 31, 2024 | -38.98% |
| Sep 30, 2024 | 16.03% |
| Jun 30, 2024 | 28.18% |
| Mar 31, 2024 | 202.54% |
| Dec 31, 2023 | 180.51% |
| Sep 30, 2023 | 18.99% |
| Jun 30, 2023 | 122.37% |
| Mar 31, 2023 | -48.82% |
| Dec 31, 2022 | 1,722.28% |
| Sep 30, 2022 | 9.44% |
| Jun 30, 2022 | -38.62% |
| Mar 31, 2022 | 59.68% |
| Dec 31, 2021 | -101.26% |
| Sep 30, 2021 | 19.71% |